Rare Daily Staff
Vanderbilt University Medical Center said it would integrate FDNA’s Face2Gene suite of applications into the Vanderbilt Center for Undiagnosed Diseases workflow to evaluate difficult-to-diagnose patients in its role as part of the National Institutes of Health Undiagnosed Disease Network.
Participating institutions in the Undiagnosed Disease Network use the most advanced approaches in genomics and research to search for answers for patients who have been unable to find a diagnosis. The network is made up of seven top-ranked institutions in the United States.
“FDNA’s mission aligns perfectly with Vanderbilt and the UDN,” said Dekel Gelbman, CEO, FDNA. “We are all working to find answers for patients who have waited far too long, and with this collaboration, we believe we are one step closer.”
Face2Gene is a platform that uses next-generation phenotyping technologies to analyze a patient’s facial and clinical features to highlight syndromes and genetics that may have otherwise been missed during patient evaluations.
December 5, 2017